NorthRock Partners’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.02M | Buy |
1,906
+870
| +84% | +$467K | 0.03% | 233 |
|
|
2025
Q1 | $435K | Buy |
1,036
+36
| +4% | +$15.1K | 0.01% | 376 |
|
|
2024
Q4 | $413K | Sell |
1,000
-898
| -47% | -$371K | 0.01% | 394 |
|
|
2024
Q3 | $959K | Buy |
1,898
+729
| +62% | +$368K | 0.03% | 219 |
|
|
2024
Q2 | $570K | Buy |
1,169
+114
| +11% | +$55.5K | 0.02% | 307 |
|
|
2024
Q1 | $570K | Buy |
1,055
+83
| +9% | +$44.8K | 0.02% | 323 |
|
|
2023
Q4 | $540K | Buy |
972
+446
| +85% | +$248K | 0.02% | 302 |
|
|
2023
Q3 | $230K | Buy |
+526
| New | +$230K | 0.02% | 295 |
|
|
2023
Q2 | – | Sell |
-484
| Closed | -$242K | – | 329 |
|
|
2023
Q1 | $242K | Sell |
484
-163
| -25% | -$81.5K | 0.03% | 269 |
|
|
2022
Q4 | $264K | Buy |
+647
| New | +$264K | 0.03% | 272 |
|